It should not be used in type 1 diabetes, diabetic ketoacidosis, severe gastrointestinal disease, or during pregnancy
"Today's announcement marks yet another significant next step forward in our long-standing efforts to lower prescription drug prices," AARP's CEO Dr
He added that while the drugs at the center of Thursdays announcement are not a panacea or a silver bullet, he predicted the nation is going to see a marked decline in all these things because of this historic agreement. Combined with dietary changes and physical exercise, Kennedy said expanded access to Wegovy and Zepbound is going to result in a decline in costs, but also, more importantly, in the affiliations themselves. The secretary also noted that the Department of Health and Human Services is going to release its updated dietary guidelines in December, and that the Presidents Council on Sports, Fitness and Nutrition is also going to be rolling out programs to get more Americans, particularly children, into physical activity. In the meantime, theres nothing more important that we can do than lower the price of these drugs, he said
Food and Drug Administration (FDA) for managing Type 2 diabetes, and Wegovy has been FDA-approved for weight loss